CUPR Stock — Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Updated October 16, 2026.

CUPR is a Stock. Total return is -94.3% over the past 1.5 years, 142.2 points behind SPY at 47.9%.

Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company that develops and commercializes products for managing chronic wounds, including sterile blowfly larvae bio-dressing products sold under the MEDIFLY brand name for biological debridement, as well as collagen-based dressings and medical leech products derived from bullfrog collagen and other sources. The company does not currently have a stated distribution frequency or known distribution rate. This security may appeal to investors seeking exposure to specialized medical device and biotechnology companies focused on wound care innovation.

CUPR performance versus SPY

Price and return data through 2026-10-16.

Total return is -94.3% over the past 1.5 years, 142.2 points behind SPY at 47.9%. Over the past year its total return — price change plus distributions reinvested — is -74.5%. Its deepest 1-year drawdown was 81.0%.

CUPR key facts

Asset type

Stock

Asset class

Equity

Inception date

04/10/2025

Distribution frequency

None

Last close

$1.90 (as of 2026-10-16)

Market cap

$9,961,953

Average volume

320466.0

Payout ratio

0.0%

EPS

$-1.40

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CUPR risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 81.0%.

Who may consider CUPR — and who may not

It is a weaker fit for investors who need monthly cash flow (CUPR does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on CUPR

• All tickers starting with C

Tagged: Healthcare.

Frequently asked questions